Unpacking the utility of euvolemic automated transfusion in sickle cell disease
- PMID: 39010682
- DOI: 10.1111/trf.17875
Unpacking the utility of euvolemic automated transfusion in sickle cell disease
Comment on
-
Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload.Transfusion. 2024 Jan;64(1):124-131. doi: 10.1111/trf.17613. Epub 2023 Dec 8. Transfusion. 2024. PMID: 38069526 Free PMC article.
References
REFERENCES
-
- Mercure‐Corriveau N, Crowe EP, Vozniak S, Feng X, Rai H, van Denakker T, et al. Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload. Transfusion. 2024;64(1):124–131.
-
- McDowell LA, Kudaravalli P, Chen RJ, Sticco KL. Iron overload. StatPearls. Treasure Island, FL: StatPearls Publishing; 2024.
-
- Blasi A, Cid J, Beltran J, Taurà P, Balust J, Lozano M. Coagulation profile after plasma exchange using albumin as a replacement solution measured by thromboelastometry. Vox Sang. 2016;110(2):159–165.
-
- Ibrahim RB, Liu C, Cronin SM, Murphy BC, Cha R, Swerdlow P, et al. Drug removal by plasmapheresis: an evidence‐based review. Pharmacotherapy. 2007;27(11):1529–1549. https://doi.org/10.1592/phco.27.11.1529
-
- Chou ST, Jackson T, Vege S, Smith‐Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh‐matched minority donors. Blood. 2013;122(6):1062–1071.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources